ROCKWELL MEDICAL, INC. Income Tax Expense
ROCKWELL MEDICAL, INC. (RMTI) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-26
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for the quarter ending 2016-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for the quarter ending 2016-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for the quarter ending 2016-06-30 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for the quarter ending 2016-03-31 was $404.53K.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for fiscal 2025 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for fiscal 2024 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for fiscal 2023 was $0.00.
- ROCKWELL MEDICAL, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $404.53K 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $404.53K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2017-08-09 | $404.53K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $404.53K 10-K · filed 2018-03-15 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-15 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | ||
| 2012-12-31 | $0.00 10-K · filed 2015-03-03 | |||
| 2011-12-31 | $47.00 10-K · filed 2013-03-18 | $2.00K derived: sum of 2 quarters · filed 2013-03-18 | $2.00K derived: sum of 3 quarters · filed 2013-03-18 | $2.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | $1.96K 10-K · filed 2013-03-18 | $1.96K derived: sum of 2 quarters · filed 2013-03-18 | $1.96K 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | $0.00 10-Q · filed 2011-08-05 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-05 | $0.00 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |